Humanized mice for the study of type 1 diabetes and beta cell function.

Area of Science:

• Endocrinology and Metabolism
• Immunology
• Regenerative Medicine

Background:

• Rodent models are crucial for diabetes research but often fail to predict human clinical outcomes.
• Existing models of autoimmune type 1 diabetes in rodents have shown limited translatability to human clinical trials.
• There is a critical need for improved preclinical models that better represent human physiology.

Purpose of the Study:

• To introduce novel humanized mouse models for studying key aspects of diabetes.
• To facilitate research in human islet stem/progenitor cells, islet allograft rejection, and human immunity/autoimmunity.
• To bridge the gap between in vitro/rodent studies and clinical translation in diabetes.

Main Methods:

• Development and utilization of genetically modified mice engrafted with human cells and tissues.
• Application of these humanized models to investigate human islet cell biology and immune responses.
• Comparative analysis of outcomes in humanized models versus traditional rodent models.

Main Results:

• Humanized mouse models enable the study of human islet stem and progenitor cells in a living system.
• These models allow for the investigation of human islet allograft rejection dynamics.
• They provide a platform to study human immunity and autoimmunity relevant to type 1 diabetes.

Conclusions:

• Humanized mouse models represent a significant advancement for preclinical diabetes research.
• These models offer a more accurate preclinical bridge for translating discoveries to the clinic.
• The developed models are essential for improving the success of type 1 diabetes clinical trials.